Market Overview

Zoetis Soars On News Of Ackman Stake

Related ZTS
Earnings Scheduled For August 8, 2017
Watch These 7 Huge Call Purchases In Tuesday Trade
Stocks With Rising Relative Strength: Zoetis (Investor's Business Daily)

It was reported Tuesday that activist investor Bill Ackman has accumulated a "roughly $2 billion stake" in Zoetis Inc (NYSE: ZTS).

The stock spiked on the news, soaring nearly 10 percent.

According to the report, Ackman “could push the animal-health company to sell itself to a
 large drug maker like Valeant Pharmaceuticals International Inc.”

“Mr. Ackman's Pershing Square Capital Management LP has built the stake, which amounts to roughly 10 percent of Zoetis, with fellow hedge fund Sachem Head Capital Management LP,” according to sources familiar with the developments.

A Dow Jones report noted that a “spokesman for Florham Park, N.J.-based Zoetis, which has a market value of about $20 billion, said the company got a call from Mr. Ackman regarding
the investment, but declined to comment on it.”

Zoetis closed at $43.72, up 8.8 percent.

Posted-In: Dow Jones Pershing Square Sachem Head CapitalNews


Related Articles (ZTS)

View Comments and Join the Discussion!